TRUSTEES OF DARTMOUTH COLLEGE
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary, Private
- Established
- 1769-12-13
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.dartmouth.edu
Nuvalent Appoints Grant Bogle to Board of Directors, Strengthening Oncology Focus
• Nuvalent, a clinical-stage biopharmaceutical company, has appointed Grant Bogle to its Board of Directors to leverage his expertise in oncology and biotechnology.
• Bogle's experience includes leadership roles at Epizyme, TESARO, and US Oncology, guiding numerous oncology products from development to commercialization.
• Nuvalent anticipates pivotal data readouts in 2025 from trials of its kinase inhibitors and plans to initiate a Phase 3 trial for ALK-positive NSCLC.
• Nuvalent is focused on developing precisely targeted therapies for cancer, aiming to overcome resistance and improve outcomes for patients with kinase-driven tumors.
Syneos Health Announces Webinar on Healthcare Innovation and Digital Transformation Trends for 2025
• Syneos Health is hosting a forward-looking webinar on January 28th exploring emerging healthcare trends, focusing on digital health, biotechnology advances, and personalized medicine solutions.
• Industry experts will discuss strategies to enhance clinical trial efficiency and diversity, while examining how omnichannel approaches are revolutionizing patient and provider engagement.
• The panel features distinguished healthcare leaders including Dr. Jane Williams, Batisha Anson, and Stephen Hoelper, bringing expertise in neuroscience, health equity, and digital healthcare innovation.
© Copyright 2025. All Rights Reserved by MedPath